| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |